RFP QuestBeta
ClosedStage · contract

Department of Health and Social Care (London)

Respiratory Syncytial Virus Modelling for Immunisation_2nd Opinion

R&DCPV 73000000
Value£29k
Deadline31 Jan 2023
Published27 Jun 2023
RegionUK-wide
Timeline
Published 27 Jun 2023ClosedCloses 31 Jan 2023
Contract value in context
£29ktotal contract value
median £66k
this tender£0£561k

This sits below the typical range for Research & Development contracts — a smaller, more accessible award. Based on 20,405 valued Research & Development tenders in our corpus.

Match for your company
Sign up free to see how well this tender matches your company — the score, the signals that align, and where the gaps are.
The brief

Delivery of a Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants in England/Wales/UK: second opinion model for Joint Committee on Immunisation and Vaccination (JCVI)

Buyer intelligence

Make the case to bid

Reveal who to approach at Department of Health and Social Care (London), and generate a go-to-market strategy from their news, accounts and people.

Source & provenance
OCID
4fc35ae3-e4fa-438f-b897-4d91280bdc11
Stage
contract · Contract
Source
Contracts Finder
Buyer ref
CF-1686000D0O000000rwimUAA
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Research & Development

Assembling the market network…

Department of Health and Social Care (London)’s tender network

Assembling the network…